Cancer
Liquid Biopsy-Based Multi-Cancer Early Detection Gains Attention as Breakthrough in Cancer Screening
Liquid biopsy-based multi-cancer early detection (MCED) is being viewed as a breakthrough in cancer screening and prevention due to its ability to detect multiple cancers simultaneously with minimal invasiveness and high patient compliance. Current cancer screening methods, such as mammography, colonoscopy, and low-dose computed tomography (LDCT), are limited in scope